Avid Bioservices (NASDAQ:CDMO) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.06) by 50 percent. The company reported quarterly sales of $40.17 million which missed the analyst consensus estimate of $40.76 million by 1.45 percent. This is a 6.49 percent increase over sales of $37.73 million the same period last year.